The loss of the owners of Medscan (part of the management contour of Rosatom State Corporation) for the first half of 2026, according to IFRS, amounted to 745.5 million rubles against a loss of 1.38 billion rubles a year earlier. This is stated in the company's report.
Revenue increased by 13.5% to RUB 17.93 billion from RUB 15.79 billion, and EBITDA increased by 25.4% to RUB 2.77 billion from RUB 2.2 billion.
Labor costs increased to 1.32 billion rubles from 1.1 billion rubles.
Medscan Group is one of the leaders of the non-governmental healthcare sector in the Russian Federation and offers a full range of high-tech medical care, the company's report says.
The main activities of the group are: diagnostics, outpatient care for adults and children, planned and emergency surgery, rehabilitation, treatment of oncological diseases, as well as the provision of medical laboratories.
The net loss of Medscan Group according to IFRS for 2025 was 3.3 billion rubles against a loss of 1.3 billion rubles a year earlier. Revenue increased by 16% to 32.6 billion rubles from 28 billion rubles, gross profit — by 21% to 13.2 billion rubles from 10.9 billion rubles, EBITDA — by 28% to 5 billion rubles from 3.9 billion rubles.
The State Atomic Energy Corporation Rosatom is a multidisciplinary holding company that unites assets in the energy, mechanical engineering, and construction sectors. Rosatom's activities also include the production of innovative nuclear and non-nuclear products, carbon-free electricity, the development of scientific and technological potential, the development of the Northern Sea Route and environmental projects.
